Clinical trial NCT04737499: Culturally Appropriate Strategies for Chinese Americans With Diabetes (CASCADe)
Official title: Implementation and Evaluation of A Culturally Tailored Diabetes Self-Management Program for Chinese Americans
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Type 2 Diabetes
Keywords: Chinese Americans
Type 2 Diabetes
mHealth
Diabetes Self-Management and Education
Lead sponsor: Claremont Graduate University
Sponsor class: OTHER
Collaborators: name: AHMC Health Foundation
First posted: 2021-02-04
Enrollment: 14
Sex: ALL
Minimum age (years): 21
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: Single group pre- and post-test design
Primary purpose: TREATMENT

Brief summary: The project aimed to evaluate the implementation process and efficacy of a culturally tailored Diabetes Self-Management and Education (DSME) program with mobile health (mHealth) technology integration, entitled Culturally Appropriate Strategies for Chinese Americans with Diabetes (CASCADe), among Chinese American adults with Type 2 diabetes.

Detailed description: The CASCADe program includes 1) a home visit for training of monitoring devices use, WeChat app and acquiring family support, 2) 8 weekly education sessions with a combined format of group class, games, food demonstration, group exercise, video and discussion, 3) WeChat follow-up on education tips, monitoring data summary, and group discussion. The monitoring system used a smartphone to coordinate cloud data transmission from a set of wireless devices to capture daily monitoring data on physical activity, body weight, blood pressure and blood glucose levels. WeChat app was used to facilitate behavioral self-monitoring by providing daily messages related to diabetes education curriculum, weekly summary reports on monitoring data as well as reinforcement messages and group discussion on readings and monitoring results implication. A single group pre-post-test design was adopted to evaluate changes of primary (HbA1c) and secondary (Self-efficacy, quality of life and stress coping) outcomes assessed at pre and post of intervention. Engagement and adherence in education sessions and self-monitoring system, and satisfaction with the content and delivery of intervention were also evaluated at the end of the study.

Eligibility criteria: Inclusion Criteria:

* have been diagnosed with Type 2 diabetes
* having been managing diabetes with diet, oral hypoglycemic agents or insulin, or both
* confirmed HbA1c level \>=6.5% and \<10%
* 21-75 years old
* residents of San Gabriel Valley
* speak and understand of Mandarin
* willing to use the smartphone-based monitoring devices provided by the project.

Exclusion Criteria:

* unable or unwilling to give informed consent
* plan to move out of the area within the 1-year participation study period
* are or plan to be pregnant or breastfeeding in the next 12 months
* have a condition that inhibits movement (e.g., unable to walk unaided, or cannot walk 1/4 mile without stopping)
* have major physical disability or condition that prevents them from participating in person.

Primary outcomes:
measure: Change of Concentration of HbA1c
timeFrame: Change from baseline HbA1c at 3 months
Secondary outcomes:
measure: Change of Score of Self-efficacy
timeFrame: Change from baseline Self-efficacy score at 3 months
measure: Change of Score of Quality of life
timeFrame: Change from baseline Quality of life score at 3 months
Other outcomes:
Locations:
city: Claremont
country: United States
facility: Clarement Graduate University
state: California
Study officials:
References: